Mårten Segelmark
91 – 100 of 204
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
C1-inhibitor decreases the release of vasculitis-like chemotactic endothelial microvesicles
- Contribution to journal › Article
-
Mark
Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts
- Contribution to journal › Article
-
Mark
Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis
- Contribution to journal › Article
-
Mark
The European Vasculitis Society 2016 Meeting Report
- Contribution to journal › Article
-
Mark
Microvesicle transfer of kinin B1-receptors is a novel inflammatory mechanism in vasculitis
- Contribution to journal › Article
-
Mark
Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis
- Contribution to journal › Article
- 2016
-
Mark
Home- or Institutional Hemodialysis? - a Matched Pair-Cohort Study Comparing Survival and Some Modifiable Factors Related to Survival
- Contribution to journal › Article
-
Mark
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
- Contribution to journal › Article
-
Mark
Rituximab for treatment of severe renal disease in ANCA associated vasculitis
- Contribution to journal › Article
-
Mark
Long-term kidney transplant outcomes in primary glomerulonephritis : Analysis from the ERA-EDTA registry
- Contribution to journal › Article
